News

The Sifted Podcast Episode Two: The Companies Going Psychedelic

In this episode, you’ll hear from Dr Carol Routledge, Chief Medical and Scientific Officer at Small Pharma, talk about how psychedelics help the brain break out of negative cycles.

The introduction article for the podcast of episode two also has some excellent charts of psychedelics in numbers including the industry growth through both VC startup investment and the rapid growth in Value of European psychedelic startups.

ACCESS EPISODE TWO OF THE SIFTED PODCAST HERE

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: